MiBio Meeting Series

The MIBio conference series engages leading experts from industry and academia in a discussion on how the latest molecular interaction-based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly, and safer therapeutic products.

MiBio 2023 (11th)

The 11th MIbio2023 conference was held at the exquisite Howard Theatre, Downing College of University of Cambridge in Cambridge, UK. This one-day event was marked by a series of enlightening presentations, exciting posters and provided invaluable networking opportunities with representatives from both academia and industry. This conference was co-organized by the Royal Society of Chemistry (RSC) Formulation Science and Technology Group (FSTG), and the Joint Colloids Group of the Society of Chemical Industry (SCI) and RSC, together with the Academy of Pharmaceutical Science (APS).

This year's conference centred around cutting-edge advancements in biopharmaceutical product development. Dr. Didier Pertuy (Sanofi) discussed how drug delivery technologies are shaped by diverse modalities, emphasizing customer needs and ecosystems. Dr. Katie Cornish (AstraZeneca) explored the application of human factors in patient-centric dosage and device development, emphasizing a user-centred approach. Dr. Maria Chiara Arno (University of Birmingham) introduced a novel method for precision polymer particle manufacturing, potentially revolutionizing drug delivery applications. Dr. Stephen Buckley(Novo Nordisk), presented advanced strategies for oral peptide/protein delivery, delving into chemistry, enhancers, and novel devices/technologies. Additionally, Dr. Alistair Taverner (University of Bath) shared insights on the Permeable Inhibitor of Phosphatase (PIP) peptide, enhancing oral peptide absorption by targeting endogenous biological permeability regulation. Lastly, Professor Paul Dalby (University College London) elucidated the degradation and stabilization mechanisms in biologic formulations, employing biophysical analysis and molecular dynamics (MD) simulations.

Beyond the exceptional presentations, panel discussions explored strategies for biopharmaceutical drug delivery, including enhanced devices, patient-centric designs, and human factors. Formulation challenges for parenteral (subcutaneous, intravenous) administration were addressed, alongside innovative approaches involving alternative administration routes.

Finally, being a part of the MIBio conference core community and contributing to the organization of this event was truly fantastic personal experience, thanks for all the great work from the MIBio orgnaisation committee members @Jan Jezek, @Darton, Nicholas, @Perez, Bernardo /US, @Tejash Shah, @Stephen Harding, @Nacho Martin-Fabiani-Carrato and @Deborah Reed-Aspley.

Many thanks and look forward to catching up with you next week in the committee meeting .

 

MiBio 2023  ♦ MiBio 2022  ♦  MiBio 2019  ♦  MiBio 2018

MiBio 2016  ♦  MiBio 2015  MiBio 2014   MiBio 2013  ♦  MiBio 2012